華檢醫療(01931.HK)完成首批以太坊(ETH)的合規購買 首批合共買入5190枚以太坊(ETH)
格隆匯8月8日丨華檢醫療(01931.HK)宣佈,爲推進集團「全球增強版以太坊(ETH)金庫」戰略的快速落地,經董事會決議批準,公司將可最多動用8.8億港元於公開市場購買以太坊(ETH)作爲儲備資產。公司將通過自有資金及透過募集資金活動籌集的資金來加大購買額度,將依上市規則適時作出進一步公告,包括但不限於召開股東大會通過加大購買額度等。公司已通過香港持牌虛擬資產交易所HashKey Exchange完成首批以太坊(ETH)的合規購買,並計劃通過定投式加倉策略持續增持,目標成爲港股市場乃至全球以太坊(ETH)儲備規模領先的上市公司。
截至公告日,公司首批合共買入5,190枚以太坊(ETH),每枚平均價格爲28,798.21港元(即爲3,661美元),總交易對價1.4947億港元。首批以太坊(ETH)買入已通過HashKey Exchange於公開市場完成,資金來源爲集團現有現金儲備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.